Medical Care

Global Influenza Diagnostics Market Research Report 2024

Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
The global Influenza Diagnostics market was valued at US$ 2335.5 million in 2023 and is anticipated to reach US$ 3599.9 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030.
North America is the largest consumption place, with a consumption marker share nearly 53%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
The main manufacturers are BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific etc. BD is the largest manufacturer with about 19% market share.
This report aims to provide a comprehensive presentation of the global market for Influenza Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Diagnostics.
Report Scope
The Influenza Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Influenza Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Influenza Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
Segment by Type
RIDT
RT-PCR
Cell Culture
Others
Segment by Application
Hospitals
POCT
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Influenza Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Influenza Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 RIDT
1.2.3 RT-PCR
1.2.4 Cell Culture
1.2.5 Others
1.3 Market by Application
1.3.1 Global Influenza Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 POCT
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Influenza Diagnostics Market Perspective (2019-2030)
2.2 Influenza Diagnostics Growth Trends by Region
2.2.1 Global Influenza Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Influenza Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Influenza Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Influenza Diagnostics Market Dynamics
2.3.1 Influenza Diagnostics Industry Trends
2.3.2 Influenza Diagnostics Market Drivers
2.3.3 Influenza Diagnostics Market Challenges
2.3.4 Influenza Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Influenza Diagnostics Players by Revenue
3.1.1 Global Top Influenza Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Influenza Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Influenza Diagnostics Revenue
3.4 Global Influenza Diagnostics Market Concentration Ratio
3.4.1 Global Influenza Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Influenza Diagnostics Revenue in 2023
3.5 Influenza Diagnostics Key Players Head office and Area Served
3.6 Key Players Influenza Diagnostics Product Solution and Service
3.7 Date of Enter into Influenza Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Influenza Diagnostics Breakdown Data by Type
4.1 Global Influenza Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Influenza Diagnostics Forecasted Market Size by Type (2025-2030)
5 Influenza Diagnostics Breakdown Data by Application
5.1 Global Influenza Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Influenza Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Influenza Diagnostics Market Size (2019-2030)
6.2 North America Influenza Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Influenza Diagnostics Market Size by Country (2019-2024)
6.4 North America Influenza Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Influenza Diagnostics Market Size (2019-2030)
7.2 Europe Influenza Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Influenza Diagnostics Market Size by Country (2019-2024)
7.4 Europe Influenza Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Influenza Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Influenza Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Influenza Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Influenza Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Influenza Diagnostics Market Size (2019-2030)
9.2 Latin America Influenza Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Influenza Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Influenza Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Influenza Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Influenza Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Influenza Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Influenza Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Detail
11.1.2 BD Business Overview
11.1.3 BD Influenza Diagnostics Introduction
11.1.4 BD Revenue in Influenza Diagnostics Business (2019-2024)
11.1.5 BD Recent Development
11.2 Abbott (Include Alere)
11.2.1 Abbott (Include Alere) Company Detail
11.2.2 Abbott (Include Alere) Business Overview
11.2.3 Abbott (Include Alere) Influenza Diagnostics Introduction
11.2.4 Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2019-2024)
11.2.5 Abbott (Include Alere) Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Influenza Diagnostics Introduction
11.3.4 Roche Revenue in Influenza Diagnostics Business (2019-2024)
11.3.5 Roche Recent Development
11.4 SIEMENS
11.4.1 SIEMENS Company Detail
11.4.2 SIEMENS Business Overview
11.4.3 SIEMENS Influenza Diagnostics Introduction
11.4.4 SIEMENS Revenue in Influenza Diagnostics Business (2019-2024)
11.4.5 SIEMENS Recent Development
11.5 Analytik Jena
11.5.1 Analytik Jena Company Detail
11.5.2 Analytik Jena Business Overview
11.5.3 Analytik Jena Influenza Diagnostics Introduction
11.5.4 Analytik Jena Revenue in Influenza Diagnostics Business (2019-2024)
11.5.5 Analytik Jena Recent Development
11.6 Quidel
11.6.1 Quidel Company Detail
11.6.2 Quidel Business Overview
11.6.3 Quidel Influenza Diagnostics Introduction
11.6.4 Quidel Revenue in Influenza Diagnostics Business (2019-2024)
11.6.5 Quidel Recent Development
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Detail
11.7.2 Thermo Fisher Business Overview
11.7.3 Thermo Fisher Influenza Diagnostics Introduction
11.7.4 Thermo Fisher Revenue in Influenza Diagnostics Business (2019-2024)
11.7.5 Thermo Fisher Recent Development
11.8 Meridian Bioscience
11.8.1 Meridian Bioscience Company Detail
11.8.2 Meridian Bioscience Business Overview
11.8.3 Meridian Bioscience Influenza Diagnostics Introduction
11.8.4 Meridian Bioscience Revenue in Influenza Diagnostics Business (2019-2024)
11.8.5 Meridian Bioscience Recent Development
11.9 BioMerieux
11.9.1 BioMerieux Company Detail
11.9.2 BioMerieux Business Overview
11.9.3 BioMerieux Influenza Diagnostics Introduction
11.9.4 BioMerieux Revenue in Influenza Diagnostics Business (2019-2024)
11.9.5 BioMerieux Recent Development
11.10 Sekisui Diagnostics
11.10.1 Sekisui Diagnostics Company Detail
11.10.2 Sekisui Diagnostics Business Overview
11.10.3 Sekisui Diagnostics Influenza Diagnostics Introduction
11.10.4 Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2019-2024)
11.10.5 Sekisui Diagnostics Recent Development
11.11 Response Biomedical
11.11.1 Response Biomedical Company Detail
11.11.2 Response Biomedical Business Overview
11.11.3 Response Biomedical Influenza Diagnostics Introduction
11.11.4 Response Biomedical Revenue in Influenza Diagnostics Business (2019-2024)
11.11.5 Response Biomedical Recent Development
11.12 SA Scientific
11.12.1 SA Scientific Company Detail
11.12.2 SA Scientific Business Overview
11.12.3 SA Scientific Influenza Diagnostics Introduction
11.12.4 SA Scientific Revenue in Influenza Diagnostics Business (2019-2024)
11.12.5 SA Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Influenza Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of RIDT
Table 3. Key Players of RT-PCR
Table 4. Key Players of Cell Culture
Table 5. Key Players of Others
Table 6. Global Influenza Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Influenza Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Influenza Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Influenza Diagnostics Market Share by Region (2019-2024)
Table 10. Global Influenza Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Influenza Diagnostics Market Share by Region (2025-2030)
Table 12. Influenza Diagnostics Market Trends
Table 13. Influenza Diagnostics Market Drivers
Table 14. Influenza Diagnostics Market Challenges
Table 15. Influenza Diagnostics Market Restraints
Table 16. Global Influenza Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Influenza Diagnostics Market Share by Players (2019-2024)
Table 18. Global Top Influenza Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Diagnostics as of 2023)
Table 19. Ranking of Global Top Influenza Diagnostics Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Influenza Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Influenza Diagnostics Product Solution and Service
Table 23. Date of Enter into Influenza Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Influenza Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Influenza Diagnostics Revenue Market Share by Type (2019-2024)
Table 27. Global Influenza Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Influenza Diagnostics Revenue Market Share by Type (2025-2030)
Table 29. Global Influenza Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Influenza Diagnostics Revenue Market Share by Application (2019-2024)
Table 31. Global Influenza Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Influenza Diagnostics Revenue Market Share by Application (2025-2030)
Table 33. North America Influenza Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Influenza Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Influenza Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Influenza Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Influenza Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Influenza Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Influenza Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Influenza Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Influenza Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Influenza Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Influenza Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Influenza Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Influenza Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Influenza Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Influenza Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 48. BD Company Detail
Table 49. BD Business Overview
Table 50. BD Influenza Diagnostics Product
Table 51. BD Revenue in Influenza Diagnostics Business (2019-2024) & (US$ Million)
Table 52. BD Recent Development
Table 53. Abbott (Include Alere) Company Detail
Table 54. Abbott (Include Alere) Business Overview
Table 55. Abbott (Include Alere) Influenza Diagnostics Product
Table 56. Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2019-2024) & (US$ Million)
Table 57. Abbott (Include Alere) Recent Development
Table 58. Roche Company Detail
Table 59. Roche Business Overview
Table 60. Roche Influenza Diagnostics Product
Table 61. Roche Revenue in Influenza Diagnostics Business (2019-2024) & (US$ Million)
Table 62. Roche Recent Development
Table 63. SIEMENS Company Detail
Table 64. SIEMENS Business Overview
Table 65. SIEMENS Influenza Diagnostics Product
Table 66. SIEMENS Revenue in Influenza Diagnostics Business (2019-2024) & (US$ Million)
Table 67. SIEMENS Recent Development
Table 68. Analytik Jena Company Detail
Table 69. Analytik Jena Business Overview
Table 70. Analytik Jena Influenza Diagnostics Product
Table 71. Analytik Jena Revenue in Influenza Diagnostics Business (2019-2024) & (US$ Million)
Table 72. Analytik Jena Recent Development
Table 73. Quidel Company Detail
Table 74. Quidel Business Overview
Table 75. Quidel Influenza Diagnostics Product
Table 76. Quidel Revenue in Influenza Diagnostics Business (2019-2024) & (US$ Million)
Table 77. Quidel Recent Development
Table 78. Thermo Fisher Company Detail
Table 79. Thermo Fisher Business Overview
Table 80. Thermo Fisher Influenza Diagnostics Product
Table 81. Thermo Fisher Revenue in Influenza Diagnostics Business (2019-2024) & (US$ Million)
Table 82. Thermo Fisher Recent Development
Table 83. Meridian Bioscience Company Detail
Table 84. Meridian Bioscience Business Overview
Table 85. Meridian Bioscience Influenza Diagnostics Product
Table 86. Meridian Bioscience Revenue in Influenza Diagnostics Business (2019-2024) & (US$ Million)
Table 87. Meridian Bioscience Recent Development
Table 88. BioMerieux Company Detail
Table 89. BioMerieux Business Overview
Table 90. BioMerieux Influenza Diagnostics Product
Table 91. BioMerieux Revenue in Influenza Diagnostics Business (2019-2024) & (US$ Million)
Table 92. BioMerieux Recent Development
Table 93. Sekisui Diagnostics Company Detail
Table 94. Sekisui Diagnostics Business Overview
Table 95. Sekisui Diagnostics Influenza Diagnostics Product
Table 96. Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2019-2024) & (US$ Million)
Table 97. Sekisui Diagnostics Recent Development
Table 98. Response Biomedical Company Detail
Table 99. Response Biomedical Business Overview
Table 100. Response Biomedical Influenza Diagnostics Product
Table 101. Response Biomedical Revenue in Influenza Diagnostics Business (2019-2024) & (US$ Million)
Table 102. Response Biomedical Recent Development
Table 103. SA Scientific Company Detail
Table 104. SA Scientific Business Overview
Table 105. SA Scientific Influenza Diagnostics Product
Table 106. SA Scientific Revenue in Influenza Diagnostics Business (2019-2024) & (US$ Million)
Table 107. SA Scientific Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Influenza Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Influenza Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. RIDT Features
Figure 4. RT-PCR Features
Figure 5. Cell Culture Features
Figure 6. Others Features
Figure 7. Global Influenza Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Influenza Diagnostics Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. POCT Case Studies
Figure 11. Others Case Studies
Figure 12. Influenza Diagnostics Report Years Considered
Figure 13. Global Influenza Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Influenza Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Influenza Diagnostics Market Share by Region: 2023 VS 2030
Figure 16. Global Influenza Diagnostics Market Share by Players in 2023
Figure 17. Global Top Influenza Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Diagnostics as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Influenza Diagnostics Revenue in 2023
Figure 19. North America Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Influenza Diagnostics Market Share by Country (2019-2030)
Figure 21. United States Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Influenza Diagnostics Market Share by Country (2019-2030)
Figure 25. Germany Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Influenza Diagnostics Market Share by Region (2019-2030)
Figure 33. China Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Influenza Diagnostics Market Share by Country (2019-2030)
Figure 41. Mexico Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Influenza Diagnostics Market Share by Country (2019-2030)
Figure 45. Turkey Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. BD Revenue Growth Rate in Influenza Diagnostics Business (2019-2024)
Figure 48. Abbott (Include Alere) Revenue Growth Rate in Influenza Diagnostics Business (2019-2024)
Figure 49. Roche Revenue Growth Rate in Influenza Diagnostics Business (2019-2024)
Figure 50. SIEMENS Revenue Growth Rate in Influenza Diagnostics Business (2019-2024)
Figure 51. Analytik Jena Revenue Growth Rate in Influenza Diagnostics Business (2019-2024)
Figure 52. Quidel Revenue Growth Rate in Influenza Diagnostics Business (2019-2024)
Figure 53. Thermo Fisher Revenue Growth Rate in Influenza Diagnostics Business (2019-2024)
Figure 54. Meridian Bioscience Revenue Growth Rate in Influenza Diagnostics Business (2019-2024)
Figure 55. BioMerieux Revenue Growth Rate in Influenza Diagnostics Business (2019-2024)
Figure 56. Sekisui Diagnostics Revenue Growth Rate in Influenza Diagnostics Business (2019-2024)
Figure 57. Response Biomedical Revenue Growth Rate in Influenza Diagnostics Business (2019-2024)
Figure 58. SA Scientific Revenue Growth Rate in Influenza Diagnostics Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies